Amgen (AMGN) Debt Ratio (2009 - 2026)
Amgen (AMGN) posted quarterly Debt Ratio of 0.62 for Q1 2026, down 3.49% year-over-year from 0.64 in Q1 2025, and up 2.8% quarter-over-quarter from 0.6 in Q4 2025.
Amgen (AMGN) Debt Ratio (2009 - 2026) Analysis & Trends
Amgen's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.62 for Q1 2026.
- In Q1 2026, Debt Ratio fell 3.49% year-over-year to 0.62; the TTM figure through Mar 2026 stood at 0.62 (down 3.49% YoY), while the FY2025 annual figure was 0.6, down 7.89% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.62, up from 0.6 in the prior quarter.
- The five-year high for Debt Ratio was 0.75 in Q2 2024, with the low at 0.6 in Q4 2022.
- The 5-year median for Debt Ratio is 0.65 (2024), against an average of 0.66.
- The sharpest annual moves came in 2022 and 2025: Debt Ratio climbed 22.0% in 2022, then dropped 12.15% in 2025.
- Amgen's Debt Ratio stood at 0.6 in 2022, then increased by 11.21% to 0.67 in 2023, then fell by 1.6% to 0.65 in 2024, then declined by 7.89% to 0.6 in 2025, then advanced by 2.8% to 0.62 in 2026.
- Business Quant data shows AMGN's Debt Ratio at 0.62 in Q1 2026, 0.6 in Q4 2025, and 0.63 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.25 Bn | 628.49 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 466.16 Bn | 459.59 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 374.06 Bn | 366.92 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 299.37 Bn | 291.68 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 256.40 Bn | 251.50 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 235.27 Bn | 221.28 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 180.36 Bn | 177.18 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.69 Bn | 147.99 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 105.08 Bn | 100.92 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 54.77 Bn | 47.39 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 0.62 |
| Dec 31, 2025 | 0.60 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.65 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.75 |
| Mar 31, 2024 | 0.73 |
| Dec 31, 2023 | 0.67 |
| Sep 30, 2023 | 0.68 |
| Jun 30, 2023 | 0.68 |
| Mar 31, 2023 | 0.69 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.63 |
| Jun 30, 2022 | 0.63 |
| Mar 31, 2022 | 0.64 |
| Dec 31, 2021 | 0.55 |
| Sep 30, 2021 | 0.64 |